### Evidence Statement CG15AdultES124
Wh en basal insulin replacement is by either continuous subcutaneous insulin infusion (CSII) or multiple daily administrations of isophane (NPH) insulin, the long term administration of lispro at mealtime reduces HbA 1c ; 130 however, compared with multiple daily injections, patients using continuous subcutaneous administration of insulin (mainly those using older systems) have been at a significantly higher risk of ketoacidosis

[@Haakens_1989]

---
niceevidencecategory: Ib
...


